Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis

Area of Science:

• Neuroimmunology
• Translational Medicine
• Animal Models of Disease

Background:

• Multiple sclerosis (MS) remains poorly understood, with suboptimal treatment outcomes.
• The prevailing hypothesis posits MS as immune-mediated, with experimental allergic encephalomyelitis (EAE) as a key animal model.
• EAE is widely used to study MS pathogenesis and test potential therapies.

Purpose of the Study:

• To critically evaluate the validity of experimental allergic encephalomyelitis (EAE) as an adequate and useful animal model for multiple sclerosis (MS).
• To assess the limitations of EAE in representing the complexity of MS.
• To advocate for a re-evaluation of EAE's role in MS research, particularly in therapeutic development.

Main Methods:

• Critical review of existing literature comparing EAE and MS.
• Analysis of the pathological and clinical features of EAE in relation to MS.
• Examination of the scientific rationale for using EAE as an MS model.

Main Results:

• Credible evidence supporting EAE as a direct counterpart to MS is lacking.
• EAE primarily models acute central nervous system inflammation, differing significantly from the chronic and relapsing-remitting nature of MS.
• The utility of EAE in defining MS-specific therapies is questionable due to fundamental differences.

Conclusions:

• The validity of using EAE as a comprehensive model for multiple sclerosis is critically challenged.
• EAE may be more representative of acute inflammatory conditions than the multifaceted pathology of MS.
• A reconsideration of EAE's utilization in MS research, especially for therapy development, is warranted to advance our understanding of MS itself.